From: Abstracts from the 25th European Society for Animal Cell Technology Meeting: Cell Technologies for Innovative Therapies
Recovery [%]
Time of incubation [h]
rhIL-2
rhIFNγ
sCD25
0
100 ± 5.3
117 ± 3.8
103.7 ± 1.3
3
74.0 ± 4
72.6 ± 1.0
N.D.
6
56.7 ± 0.3
106.5 ± 4.9
21
10.9 ± 0.3
82.1 ± 2.1
93.6 ± 10.2